Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edmilson O. dos Santos
Fibroblast Growth Factor 2 Lethally Sensitizes Cancer Cells to Stress-Targeted Therapeutic Inhibitors
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Fibroblast Growth Factor Receptor 1 (FGFR1; CD331), FGFR2 and Fibroblast Growth Factor 19 (FGF19) Amplification May Help Predict Sensitivity to FGFR Inhibitors in Cancer
Science-Business eXchange
Role of Fibroblast Growth Factor Receptor 2 in Pancreatic Cancer: Potential Target for New Therapeutic Approach?
Pancreatic Disorders and Therapy
Vasohibin-2 Promotes Proliferation in Human Breast Cancer Cells via Upregulation of Fibroblast Growth Factor-2 and Growth/Differentiation Factor-15 Expression
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Targeted Disruption of Hsp70.1 Sensitizes to Osmotic Stress
EMBO Reports
Biochemistry
Genetics
Molecular Biology
Nanocarriers for Targeted Therapeutic Delivery to Cancer Cells
Science-Business eXchange
Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Rhein Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
